MAP2K4 and central nervous system cancer: ZDHHC17 over-expression could help maintain glioma cell stemness because the upregulation of the SOX2-positive cell population, whereas MAP2K4 knockdown or genistein treatment suppressed glioma stem cell (GSC) self-renewal (Figures 7A and 7B).